These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7571832)

  • 1. National infrastructures for delivery of hepatitis B vaccination to different age groups.
    Bühlmann U
    Vaccine; 1995; 13 Suppl 1():S52-3. PubMed ID: 7571832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing universal vaccination programmes: Spain.
    de la Torre J; Esteban R
    Vaccine; 1995; 13 Suppl 1():S72-4. PubMed ID: 7571839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation in Italy of a universal vaccination programme against hepatitis B.
    Bonanni P
    Vaccine; 1995; 13 Suppl 1():S68-71. PubMed ID: 7571837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VHPB: summary of strategies and recommendations. Viral Hepatitis Prevention Board.
    Hallauer J
    Vaccine; 1995; 13 Suppl 1():S61-3. PubMed ID: 7571835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience.
    Germinario C; Lopalco PL; Chirona M; Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S83-5. PubMed ID: 10683558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy.
    Bonanni P; Pesavento G; Bechini A; Tiscione E; Mannelli F; Benucci C; Nostro AL
    Vaccine; 2003 Jan; 21(7-8):685-91. PubMed ID: 12531340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing universal vaccination programmes: Bulgaria.
    Gatcheva N; Vladimirova N; Kourtchatova A
    Vaccine; 1995; 13 Suppl 1():S82-3. PubMed ID: 7571842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infant and adolescent hepatitis B immunization up to 1999: a global overview.
    Vryheid RE; Kane MA; Muller N; Schatz GC; Bezabeh S
    Vaccine; 2000 Dec; 19(9-10):1026-37. PubMed ID: 11137236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Success stories in the implementation of universal hepatitis B vaccination: an update on Italy.
    Bonanni P; Crovari P
    Vaccine; 1998 Nov; 16 Suppl():S38-42. PubMed ID: 9915032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.
    Mast EE; Margolis HS; Fiore AE; Brink EW; Goldstein ST; Wang SA; Moyer LA; Bell BP; Alter MJ;
    MMWR Recomm Rep; 2005 Dec; 54(RR-16):1-31. PubMed ID: 16371945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B: vaccination programmes in Europe--an update.
    Van Damme P
    Vaccine; 2001 Mar; 19(17-19):2375-9. PubMed ID: 11257363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.
    Siddiqui MR; Gay N; Edmunds WJ; Ramsay M
    Vaccine; 2011 Jan; 29(3):466-75. PubMed ID: 21073988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the infant and adolescent vaccination programmes in Italy.
    Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S31-4. PubMed ID: 10683541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global programme for control of hepatitis B infection.
    Kane M
    Vaccine; 1995; 13 Suppl 1():S47-9. PubMed ID: 7571830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity.
    del Canho R; Grosheide PM; Mazel JA; Heijtink RA; Hop WC; Gerards LJ; de Gast GC; Fetter WP; Zwijneberg J; Schalm SW
    Vaccine; 1997 Oct; 15(15):1624-30. PubMed ID: 9364693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.